An excellent program. Even though theoretically enoxaparin would the least appropriate LMWH a to use in ESRD a, there is a retrospective study by Chan, K, et al in Kidney International, 2013 describing safe use of enoxaparin in a large cohort of patients on dialysis (with reduced dose). I was surprised this article was not referenced.